Roshan Hanif A 4
4 · Aeon Global Health Corp. · Filed Jul 23, 2018
Insider Transaction Report
Form 4
Roshan Hanif A
DirectorChairman
Transactions
- Award
Restricted Stock Rights
2018-07-19+911,500→ 911,500 total→ Common Stock (911,500 underlying) - Disposition to Issuer
Convertible Note
2018-07-19→ 0 totalExercise: $1.20From: 2017-03-20Exp: 2019-03-20→ Common Stock (212,847 underlying) - Disposition to Issuer
Convertible Note
2018-07-19→ 0 totalExercise: $1.20From: 2018-03-27Exp: 2019-03-20→ Common Stock (420,376 underlying)
Footnotes (2)
- [F1]Effective on July 19, 2018 the registrant entered into a transaction with the reporting person to exchange (i) a preexisting note originally issued to the reporting person on March 20, 2017 and amended on March 27, 2018 in the aggregate principal amount of $255,417 and (ii) a preexisting note originally issued to the reporting person on March 27, 2018 in the aggregate principal amount of $504,452 for a new secured note for a maximum principal amount of $1,100,000 (the "New Note"). The New Note is not convertible into any equity securities of the registrant. The preexisting notes held by the reporting person were deemed cancelled upon the issuance of the New Note pursuant to such exchange transaction.
- [F2]Represents the right to receive 911,500 shares of common stock on February 28, 2019 pursuant to the terms of a Settlement and Restructuring Agreement dated July 19, 2018 (the "Settlement Agreement") among the reporting person, the registrant and certain other parties named therein. The shares issuable under the Settlement Agreement will be deemed earned and issued on February 28, 2019.